Stocktoria
TALPHERA, INC. TLPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-02-11
TALPHERA, INC. statistics & valuation
Market cap$53.5M
P / B3.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -48157.1% | — | -2594.3% | — | -1276.3% |
| Net margin | -51035.7% | — | -2826.0% | — | -1245.5% |
| FCF margin | — | — | -2702.3% | — | -1129.5% |
| Return on assets | -48.1% | -71.3% | -90.2% | 100.6% | -45.1% |
| Return on equity | -83.9% | -162.5% | -130.4% | 218.9% | 97.8% |
| Debt / equity | — | — | — | 0.26× | -0.38× |
| Current ratio | 5.49 | 3.56 | 2.57 | 1.78 | 2.73 |
| Revenue growth | — | -100.0% | — | -100.0% | -48.0% |
Source: SEC EDGAR filings · CIK 0001427925 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.